Skip to main content
Screener/Healthcare/Biotechnology

INBX — Inhibrx Biosciences Inc.

NASDAQ
$84.76+4.51 (+5.62%)
Small CapHealthcareHigh BetaHigh ROE
$57.30
$155.29
$79.47
$85.26
EPS (TTM)$-8.39
P/E Ratio-14.45
Dividend Yield0.82%
Market Cap$1.06B
Volume155K
Prev Close$80.28
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$33.4M$-2.15——
Q4 '25$0-$32.8M$-2.11——
Q3 '25$0-$35.3M$-2.28——
Q2 '25$1.3M-$28.7M$-1.8549.1%-2204.2%
Q1 '25$0-$43.3M$-2.80——
Q4 '24$100K-$47.9M$-3.31-589.0%-47865.0%
Q3 '24$0-$43.9M$-2.84——
Q2 '24$100K$1.9B$125.48100.0%1858011.0%
Get Your Daily Market Recap